Jounce Therapeutics Inc. (JNCE) Surged 6.7% or 1.03 To Price $16.48 On Friday


Jounce Therapeutics Inc. (JNCE) surged 6.7% or 1.03 to $16.48. It is close to 448287 shares traded, which is 123.1% compare to the average total volume 364161. The market cap of JNCE is $535.47 million. The year to date change is 15.3%. The 52 week price range is from $11.05 to $29.25. Price of JNCE have changed -23.51% during last week. It have changed -21.89% over last month, -35.00% over last 3 months, 6.33% over last 6 months and -36.08% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for JNCE is 21.81. It is 32.34% above current price. The 200-day Moving Averages for JNCE is 17.62. It is 6.92% above current price. The 52-week High is 29.25. It is 77.49% from the current price. The 52-week Low is 11.05. It is -32.95% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of JNCE is 12.21 on 2018-04-30. Short % to float is 13.42%. There are some statistics of JNCE. It is has market cap $535.47 million. The share outstanding is 32.48 million. The average volume is 364161. The revenue is 38.37M. The percent of top 15 Institution holding is 57.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of JNCE is -39.04%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of JNCE is -5.69%.


Tags:

Share this post